Subtype
Liver Neoplasm
CI-CAN-00001077Explore in graph →
Non-malignant930 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001077Explore in graph →
Clinical trials
4,334 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05397860 | Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma Treatment | unknown | N/A | 120 | Seoul National University HospitalOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT04499833 | HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma(HepatoPredict) | recruiting | N/A | 40 | Centro Hospitalar de Lisboa CentralOTHER | 1 | Jun 6, 2022 |
| clinicaltrials |
| NCT02243384 | Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma | completed | N/A | 150 | ChenJianOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT04187937 | Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections | terminated | N/A | 1 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT05391867 | Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma | unknown | N/A | 70 | Sir Salimullah Medical College Mitford HospitalOTHER_GOV | 1 | May 26, 2022 | clinicaltrials |
| NCT04843176 | Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT | unknown | N/A | 250 | The University of Hong KongOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT05369650 | To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients | unknown | N/A | 120 | West China HospitalOTHER | 1 | May 11, 2022 | clinicaltrials |
| NCT04027556 | Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction | completed | N/A | 90 | Seoul National University HospitalOTHER | 1 | May 4, 2022 | clinicaltrials |
| NCT04487704 | Camrelizumab Utilization on Patients With Advanced Liver Cancer | unknown | N/A | 1,000 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT05339581 | IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation(iPLENTY-pvtt) | unknown | N/A | 78 | RenJi HospitalOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT02866344 | Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases | terminated | N/A | 1 | Wake Forest University Health SciencesOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT01666145 | Advanced Image Guidance Utilized in Liver Surgery | completed | N/A | 14 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT02704130 | TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma | terminated | N/A | 8 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03958019 | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer(RESTORE II) | unknown | N/A | 120 | University of Dublin, Trinity CollegeOTHER | 1 | Apr 13, 2022 | clinicaltrials |
| NCT03223818 | The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients | unknown | N/A | 94 | Chinese University of Hong KongOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04659005 | Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening | completed | N/A | 178 | Chinese University of Hong KongOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04231929 | BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.(BIOPEARL-FIRST) | withdrawn | N/A | 0 | Terumo Europe N.V.INDUSTRY | 1 | Mar 28, 2022 | clinicaltrials |
| NCT01340105 | Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation | completed | N/A | 93 | Chinese University of Hong KongOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT01512407 | RCT on Adjuvant TACE After Hepatectomy for HCC(A-TECH) | completed | N/A | 58 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT01759901 | Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma | completed | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05281783 | RFA for Treatment of Intermediate Stage HCC | completed | N/A | 120 | Benha UniversityOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT05277675 | Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)(RANT) | unknown | N/A | 160 | Southwest Hospital, ChinaOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT04825470 | Liver Transplantation for Unresectable GIST Liver Metastases(TRANSGIST) | unknown | N/A | 50 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT03979547 | EXALT: EXercise Attenuates Liver Tumors Trial(EXALT) | terminated | N/A | 3 | Milton S. Hershey Medical CenterOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT05270642 | Plan for Microwave Thermal Field | unknown | N/A | 5 | Chinese PLA General HospitalOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT04212286 | Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC | completed | N/A | 115 | Tianjin Third Central HospitalOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT03322280 | TACE Combined With Iodine-125 Seeds Implantation for HCC | unknown | N/A | 270 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT05247996 | TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma | unknown | N/A | 98 | The Central Hospital of Lishui CityOTHER | 0 | Feb 21, 2022 | clinicaltrials |
| NCT05242757 | Clinical Study of MAK Immune Cells in the Treatment of PHC | unknown | N/A | 12 | Zhongnan HospitalOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT04722120 | Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC | completed | N/A | 68 | Seoul National University HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT02009176 | Laparoscope Anatomical and Aon-anatomical Hepatectomy | unknown | N/A | 110 | Shuguo Zheng, MDOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT05118451 | A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC | unknown | N/A | 420 | Zhujiang HospitalOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT05233358 | HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure | unknown | N/A | 176 | The Central Hospital of Lishui CityOTHER | 0 | Feb 10, 2022 | clinicaltrials |
| NCT05160740 | Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer(ICGMFITinPLC) | unknown | N/A | 348 | Zhujiang HospitalOTHER | 1 | Feb 4, 2022 | clinicaltrials |
| NCT05162898 | Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma. | unknown | N/A | 90 | Henan Cancer HospitalOTHER_GOV | 0 | Jan 27, 2022 | clinicaltrials |
| NCT03109262 | Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors | completed | N/A | 42 | Stanford UniversityOTHER | 1 | Jan 10, 2022 | clinicaltrials |
| NCT05068076 | Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC | completed | N/A | 21 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT03731910 | Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE | unknown | N/A | 35 | Seoul National University HospitalOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT03796819 | Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma(LND for ICC) | completed | N/A | 260 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT04847726 | Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma | completed | N/A | 110 | Seoul National University HospitalOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT03113955 | STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma | completed | N/A | 109 | Varian Medical SystemsINDUSTRY | 1 | Dec 1, 2021 | clinicaltrials |
| NCT05121571 | The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study | completed | N/A | 114 | Sun Yat-sen UniversityOTHER | 1 | Nov 26, 2021 | clinicaltrials |
| NCT03926039 | Sharing Decision-making Program for HCC Patients Treatment Decisions | completed | N/A | 70 | National Taipei University of Nursing and Health SciencesOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT05017922 | Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma | completed | N/A | 89 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05032014 | Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer | unknown | N/A | 46 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT01141478 | Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria(HCC) | terminated | N/A | 8 | Loma Linda UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03644173 | Personal Resilience Empowerment Program Study | completed | N/A | 37 | Hackensack Meridian HealthOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT01387503 | Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | completed | N/A | 74 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT04443049 | To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | unknown | N/A | 170 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT01642446 | Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension | completed | N/A | 160 | Sun Yat-sen UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jun 15, 2022source: clinicaltrials